Considerations for the use of the reticulocyte hemoglobin equivalent in daily practice
Revista Hematología ENERO - ABRIL 2020
pdf (Español (España))

Keywords

reticulocyte hemoglobin
iron deficiency
anemia

How to Cite

Fiorentini, L., Paoletti, M., García, A., García, A., Ferreras, R., Cerviño, F., & García, D. (2020). Considerations for the use of the reticulocyte hemoglobin equivalent in daily practice. Journal of Hematology, 24(1), 40–48. Retrieved from https://revistahematologia.com.ar/index.php/Revista/article/view/255

Abstract

The reticulocyte hemoglobinequivalent(Ret-He) measured by some hematological autoanalyzers provides the amount of hemoglobin present in reticulocytes. It reflects hemoglobin synthesis in hematological precursors, corresponding to the hemoglobinization of the last 48-72hours. It correlates with iron deficient erythropoiesis, so it became an effective auxiliary tool to identify iron deficiency (ID) and to diagnose iron deficiency anemia (IDA). Our objective was to evaluate the usefulness of Ret-He for the study of anemias and to determine the best cut-off for the diagnosis of IDA, as well as to analyse optimal cut-off for ID screening. We analyzed 213 patients, who were classified as without anemia(Sin-A,n:80), microcytic anemia(MiA,n:64), normocytic anemia(NA,n:59) and macrocytic anemia (MaA,n:10). Of the 213 patients, 112 had requests for other parameters of iron availability and were classified as iron deficiency (ID,n:54) and non-iron deficiency(NO-ID,n:47). The mean value(±1DE) of Ret-He(pg) was 31.48(±1.81), 21.15(±3.66), 29,07(±4.32) y 37.49(±5.08) for Sin-A, AMi, AN y AMa y 22.35(±4.72) y 31.25(±1.89) para ID y No-IDrespectively. The only group that did not show significant differences with Sin-Awas No-ID(p<0.05). Receiver operator characteristic (ROC) curve analysis shows that Ret-He has similar performance to transferrin saturation (area under the curve (AUC):0.95 and 0.96respectively) and superior to ferritin (AUC:0.90) and to mean corpuscular volume (AUC:0.88).The Cut-off with best sensitivity (S) and specificity (E) was 28.45pg(S/E:87.04/89.36%). Ret-HE<28.05pg (E:95.74% and S:81.48%) has high E for ID while Ret-He>29.90pg discards ID(S:94.44%), retaining an acceptable E(82.98%).

pdf (Español (España))

References

1. Piva E, Brugnara C, Spolaore F, Plebani M. Clinical Utility of Reticulocyte Parameters. Clin Lab Med. 2015; 35:133-163.
2. Thomas L, Franck S, Messinger M, Linssen J, Thome M, Thomas C. Reticulocyte hemoglobin measurement - comparison of two methods in the diagnosis of iron-restricted erythropoiesis. Clin Chem Lab Med. 2005; 43:1193-1202.
3. Buttarello M, Pajola R, Novello E, Mezzapelle G, Plebaniet M. Evaluation of the hypochromic erythrocyte and reticulocyte hemoglobin content provided by the Sysmex XE-5000 analyzer in diagnosis of iron deficiency erythropoiesis. Clin Chem Lab Med 2016;54:1939-1945.
4. Camargo Morkis IV, Granero Farias M, Scotti L. Determination of reference ranges for immature platelet and reticulocyte fractions and reticulocyte hemoglobin equivalent. Rev Bras Hematol Hemoter. 2016; 3 8:310-313.
5. Jarc E, Preložnik Zupan I, Buturović Ponikvar J, Snoj N, Podgornik H. Comparison of erythrocyte and reticulocyte indices for the diagnosis of iron deficiency. Zdrav Vestn. 2017; 86:19-27.
6. Toki Y, Ikuta K, Kawahara Y y col. Reticulocyte hemoglobin equivalent as a potential marker for diagnosis of iron deficiency. Int J Hematol. 2017; 106:116-125.
7. Mehta S, Goyal LK, Kaushik D y col. Reticulocyte Hemoglobin vis-a-vis Serum Ferritin as a Marker of Bone Marrow Iron Store in Iron Deficiency Anemia. J Assoc Physicians India. 2016; 64:38-42.
8. Canals C, Remacha AF, Sardá MP, Piazuelo JM, Royo MT, Romero MA. Clinical utility of the new SysmexXE2100 parameter -reticulocyte hemoglobin equivalent- in the diagnosis of anemia. Haematologica. 2005; 90:1133-1134.
9. Schoorl M, Schoorl M, Linssen J y col. Efficacy of Advanced Discriminating Algorithms for Screening on Iron-Deficiency Anemia and β-Thalassemia Trait. Am J ClinPathol. 2012; 138:300-304.
10. Barbosa Torino AB, Pererira Gilberti MF, Da Costa E, Freire de Lima GA, Zerlotti Wolf Grotto H. Evaluation of erythrocyte and reticulocyte parameters asindicative of iron deficiency in patients with anemia of chronic disease. Rev Bras Hematol Hemoter. 2015; 37:77-81.
11. Peerschke EIB, Pessin MS, Maslak P. Using the hemoglobin content of reticulocytes (RET-HE) to evaluate anemia in patients with cancer. Am J Clin Pathol. 2014; 142:506-512.
12. Reinisch W, Staun M, Bhandari S, Muñoz M. State of the iron: How to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease. Journal of Crohn's and Colitis. 2013; 7:429-440.
13. Fishbane S, Shapiro W, Dutka P, Valenzuela OF, Faubert J. A randomized trial of iron deficiency testing strategies in hemodialysis patients. Kidney International. 2001; 60:2406-2411.
14. Eckhardt AA, Freiberg MA, de la Fuente JBC, Douthat WBC, Capra RA. Utilidad clínica de la hemoglobina reticulocitaria equivalente en pacientes en hemodiálisis crónica. Revista de la Facultad de Ciencias Médicas. 2011; 68;51-55.
15. Miwa N, Akiba T, Kimata N y col. Usefulness of measuring reticulocyte hemoglobin equivalent in the management of haemodialysis patients with iron deficiency. Int Jnl Lab Hem. 2010; 32:248-255.
16. National Institute for Health and Clinical Excellence. Anaemia Management in Chronic Kidney Disease. Londres, National Institute for Health and Clinical Excellence; 2015.
17. Hayes W. Measurement of iron status in chronic kidney disease. Pediatric Nephrology. 2019; 34:605-613.
18. Brugnara C, Laufer MR, Friedman AJ. Reticulocyte hemoglobin content (CHr): early indicator of iron deficiency and response to therapy. [LETTER]. Blood. 1994 83: 3100-3101.
19. Ullrich C, Wu A, Armsby C y col. Screening healthy infants for iron deficiency using reticulocyte hemoglobin content. JAMA. 2005; 294:924-90.
20. Bakr AF, Sarette G. Measurement of reticulocyte hemoglobin content to diagnose iron deficiency in Saudi children. Eur J Pediatr. 2006; 165:442-445.
21. Organización Mundial de la Salud. Concentraciones de hemoglobina para diagnosticar la anemia y evaluar su gravedad. Ginebra, Organización Mundial de la Salud; 2011.
22. Sociedad Argentina de Hematología. Guías de Diagnóstico y Tratamiento; 2019.

All material published in the journal HEMATOLOGÍA (electronic and print version) is transferred to the Argentinean Society of Hematology. In accordance with the copyright Act (Act 11 723), a copyright transfer form will be sent to the authors of approved works, which has to be signed by all the authors before its publication. Authors should keep a copy of the original since the journal is not responsible for damages or losses of the material that was submitted. Authors should send an electronic version to the email: revista@sah.org.ar

Downloads

Download data is not yet available.